# Which Hair-Follicle Cells Seed Skin Tumors?

> Mouse lineage tracing points to long-lived stem cells in the upper hair follicle, but the result does not identify the origin of human skin cancer.

_Source: Science research article, cross-checked with PubMed, Crossref, OpenAlex and Semantic Scholar · 2026-08-17 · 6 min read · Verified against primary sources_

Canonical: https://iyu.app/e/upper-hair-follicle-stem-cells-skin-tumors

## The 60-second version

Chemically induced mouse skin tumors arose mainly from long-lived stem cells in the upper hair follicle.

**Key points**

- Fluorescent lineage tracing, single-cell transcriptomics and duplex sequencing linked cell identity to tumor formation.
- Lgr6-positive and/or Lrig1-positive upper-follicle populations predominated, while Lgr5-positive and Krt19-positive bulge cells rarely seeded tumors.
- Hras Q61L clones drove tumors after promotion; Kras-mutant clones formed tumors only when Hras was deleted, indicating pathway competition.
- The model involved mice and chemical carcinogenesis, not patients or ultraviolet-driven human skin cancer.

**Verdict.** A strong mechanistic result about cell of origin and clonal selection in one mouse model, with human relevance still to be tested.

## Full explainer

In a chemical carcinogenesis model, mouse skin tumors arose mainly from long-lived stem cells in the upper hair follicle. The work links a cell's location and identity to the mutations that later expand, but it does not establish where human skin cancers begin.

> **⚑ Caveat:** This was a mouse study using a two-stage chemical tumor protocol. It did not study patients, ultraviolet-driven skin cancer, screening, prevention or treatment, so the findings must not be read as clinical advice.


### The question — A mutation still needs a cell of origin

A tumor is not defined only by a mutation. The same altered pathway can behave differently depending on which cell carries it, where that cell sits and which growth signals arrive later. The study asked which long-lived mouse skin cells survive chemical initiation and ultimately seed visible tumors.

- **3** — main methods: lineage tracing, single-cell transcriptomics and duplex sequencing
- **2 stages** — chemical initiation followed by tumor promotion
- **Mouse** — the species and experimental boundary

Fluorescent lineage tracing followed descendants of distinct stem-cell populations. Single-cell transcriptomics resolved cell states, while duplex sequencing helped detect rare mutations with fewer ordinary sequencing errors. The design combines cell identity with clonal history rather than examining only a finished tumor.


### The location — Upper-follicle cells dominated

- **Lgr6+ and/or Lrig1+:** Long-lived stem-cell populations in the upper hair follicle; the predominant sources of tumors in this model.
- **Lgr5+ and Krt19+:** Stem-cell populations in the deeper hair-follicle bulge; tumors arose from them only very rarely.
- **Interpretation:** Follicle compartment and cell state influenced which initiated clone progressed under the protocol.

The markers identify biological populations that can overlap; they are not four clean diagnostic boxes. The robust contrast is between upper-follicle populations that commonly seeded tumors and deeper bulge populations that rarely did so under the same model.


### The mutations — Hras and Kras did not act independently

After initiation with dimethylbenzanthracene, or DMBA, tumor-promotion treatment expanded Lgr6-positive cells carrying the canonical **Hras Q61L** mutation. Spontaneous **Kras** mutations also expanded clonally, but those clones did not generate tumors unless the researchers deleted Hras.

> The study suggests that cancer-linked mutations compete within a tissue; they do not simply add independent routes to a tumor.

The authors describe this as a competitive interaction between the Hras and Kras pathways that shapes clonal selection. In practical terms, a mutation's fate depends partly on the other successful lineages sharing its environment.


### The boundary — What the experiment cannot establish

- **Species:** all causal experiments described here were in mice, not people.
- **Exposure:** the protocol used chemical initiation and promotion; ultraviolet-driven human disease may follow different routes.
- **Outcome:** the study identified tumor origins and clonal selection, not a screening marker or treatment target ready for use.
- **Sample reporting:** this is a suite of lineage-tracing and molecular experiments, not one human cohort with a single participant count.
- **Generalization:** comparable cell states and pathway competition still need direct validation in human skin and across tumor subtypes.

The useful next step is to test whether human tissue shows the same relationship among follicle compartment, mutation and clonal competition. For now, the result improves experimental models of tumor initiation; it should not change personal skin-cancer prevention or care.


## Primary sources

- [Telegram post 1418](https://t.me/CNSmydream/1418)
- [Science paper (DOI 10.1126/science.adv8291)](https://doi.org/10.1126/science.adv8291)
- [PubMed record (PMID 42275467)](https://pubmed.ncbi.nlm.nih.gov/42275467/)
- [Crossref metadata and abstract](https://api.crossref.org/works/10.1126/science.adv8291)
- [OpenAlex record (W7164297443)](https://openalex.org/W7164297443)
- [Semantic Scholar record](https://www.semanticscholar.org/paper/6c114b1ccc0e02e3d4748dc058bb08ce48d80460)

---
_Published by iyu (https://iyu.app) — the day's AI news, checked against primary sources and rewritten in plain language. Free to quote with attribution and a link to the canonical URL._